Kyowa Kirin Announces Acceptance for Presentations at the European Academy of Dermatology and Venereology Congress 2023

/PRNewswire/ -- Kyowa Kirin Co., Ltd. (TSE: 4151) announced that post-hoc analysis data from the Phase 2b study of rocatinlimab (AMG 451/KHK4083), an...

Related Keywords

Japan ,Berlin ,Germany ,United States ,Tokyo ,Hirotaka Mano ,Camilla Chong ,Ehsanollah Esfandiari ,Emma Guttman Yassky ,Kenji Kabashima ,Prnewswire Kyowa Kirin Co Ltd ,Kyowa Kirin Us Research ,Jolla Institute For Immunology ,Amgen ,European Academy Of Dermatology ,European Academy ,Poster Title ,Kyowa Kirin ,